Over the last 15 years, the management of critically ill cancer patients requiring intensive care unit admission has substantially changed. High mortality rates (75-85%) were reported 10-20 years ago in cancer patients requiring life sustaining treatments. Because of these high mortality rates, the high costs, and the moral bur den for patients and their families, ICU admission of cancer patients became controversial, or even clearly discouraged by some. As a result, the reluctance of intensivists regarding cancer patients has led to frequent refusal admission in the ICU. However, prognosis of critically ill cancer patients has been improved over the past 10 years leading to an urgent need to reappraise this reluctance. In this review, the authors sought to highlight that critical care management, including mechanical ventilation and other life sustaining therapies, may benefit to cancer patients. In addition, criteria for ICU admission are discussed, with a particular emphasis to potential benefits of early ICU-admission.
Over the last 15 years, the management of critically has been improved over the past 10 years leading to an ill cancer patients requiring intensive care unit (ICU) urgent need to reappraise this reluctance. [2, 3, [12] [13] [14] [15] admission has substantially changed. [1] [2] [3] High mortality rates (75-85%) were reported 10-20 years ago in cancer
In this review, the authors seek to highlight that critical patients requiring life sustaining treatments, especially care management, including mechanical ventilation when mechanical ventilation was needed [4] [5] [6] or in and other life sustaining therapies, may benefi t cancer recipients of hematological stem cell transplantation. [7] patients. In addition, criteria for ICU admission are discussed, with a particular emphasis to potential benefits Because of these high mortality rates, the high costs of early ICU-admission. and the moral burden for patients and their families, ICU Abstract admission of cancer patients became controversial [8, 9] or even clearly discouraged by some authors.
[10] As a result, the reluctance of intensivists regarding cancer patients has led to frequent refusal of admission in the ICU.
[11] However, prognosis of critically ill cancer patients
Improvement of Prognosis of ICU Cancer Patients: The evidence
Three factors have contributed to this trend. First advances in the treatment of solid tumors and hematological malignancies have led to a decreased mortality rates. These advances include availability of new drugs, as well as intensified treatment protocols and improvement of supportive care. In patients with non Hodgkin lymphoma and other lymphoproliferative disorders, the adjunction of rituximab to conventional chemotherapy [16] demonstrated
Free full text available from www.ijccm.org dramatical improvements in terms of event free survival. Similarly, the use of Imatinib in patients with chronic myeloid leukemia resulted in better outcomes and lower need for hematopoietic stem cell transplantation.
[17] Along this line, in patients with multiple myeloma, thalidomide and bortezomib provided substantial benefits in terms of survival.
[18] As a consequence, survival increased by 20% over the last two decades. [19] Intensive care physicians must be aware of these therapeutic advances, which have considerably modified the course of several malignancies.
Pitfalls in the Use of Scoring Systems
Different scoring systems such as the acute physiology and chronic health evaluation (APACHE) II or III, [27] simplified acute physiology score (SAPS II) [28] or mortality probability models II (MPM II) [29] have been developed to predict outcome of critically ill patients admitted to the ICU. They have all been constructed for the general population and are not accurately calibrated to predict mortality in critically ill cancer patients, tending to under estimate the mortality. [30] [31] [32] Specific cancer scoring system have been We believe that a decision to admit cancer patients to proposed, but does not seem to have any advantages the ICU must take into account this important data as to over the general prognostic models, [9, 33, 34] partly because avoid losing a chance for the patients.
they are based on heterogeneous population of medical and surgical patients with solid tumors or hematological Second, improvement in diagnostic and therapeutic malignancies. Consequently, these prognostic scores are strategies in critically ill patients have led to better not accurate enough to be used in routine management management of specific ICU diseases. Early and and none of them can be recommended to help the aggressive management of septic shock have led to intensivist at the bedside. decreased mortality rates in both cancer patients [20] and non cancer patients.
[21] Noninvasive strategies have
Classic Predictors of Death are no
been implemented in patients with acute respiratory
Longer Relevant
failure, for both diagnostic procedures and noninvasive ventilation. [1, 22, 23] Improvement in the management of Underlying malignancy specific critically ill cancer patients such as acute tumor
In the decision making process of ICU admission lysis syndrome and acute respiratory failure will be of cancer patients, the prognosis of the underlying developed in this issue of the Journal. [24] malignancy is frequently considered. However, the respective influences of the severity of both the underlying Third, efforts have been made in order to identify disease and the acute illness on patient's outcome have patients who are likely to benefit from ICU admission [11] to be clearly separated. and to improve triage of cancer patients referred to the ICU. A prospective longitudinal study performed in
In a series of patients with hematological malignancies, France in 2001 showed that cancer patients were at Massion et al, evaluated the ICU and in-hospital prognosis high risk to be refused admission.
[25] However, more according to the patient's long term prognosis. [13] Patients recently, a national Swiss survey about admission to were separated in three groups according to the intensive care showed that doctors do not discriminate estimated three year prognosis: good, intermediate or against cancer when deciding on admission to the ICU, poor if their three-year survival probability was >50%, 20 suggesting that doctor's perception of therapeutic options to 50%, of <20%. Neither ICU nor in-hospital mortality for malignancies may be changing. [26] was correlated with long-term prognosis, but there was However, decision to admit or refuse ICU admission for cancer patients remains a difficult decision based on complex criteria, including objective and subjective data. [25] It should be reminded that classic predictors of mortality (neutropenia, physiological severity, autologous stem cell transplantation) are no longer relevant and should not be used to base a decision of ICU admission. a strong association between short-term prognosis and acute organ dysfunction. Consequently, the reluctance to admit patient with hematological malignancies based on the prognosis of the underlying malignancy is no longer justified. Obviously, this is in relation with a previous triage performed by hematologists and oncologists. Also, this cannot apply to patients with advanced malignancies and short-term predicted survival (i.e., life expectancy < 6 months for some authors), in whom ICU admission is not justified.
[13]
Neutropenia
Because of their increased risk for severe bacterial and fungal infections, neutropenic patients are exposed to life-threatening complications. Based on the literature published over the last 20 years, neutropenia is considered to be associated with poor prognosis in autologous and allogeneic HSCT is widely different from one another, caution is needed when analyzing studies which pool both types of patients.
Along this line, in the study by Kassawneh et al, homogeneous patients with autologous HSCT who required mechanical ventilation were analysed. [3] The authors reported an improvement of the prognosis over time and a 35% hospital survival rate, suggesting that critically ill cancer patients. However, several studies ICU admission was not futile. The authors concluded have shown that neither the neutrophil count, [9, 35, 36] nor that patients undergoing autologous HSCT should be neutropenia duration [36] were associated with prognosis. considered and managed as patients with hematological Similarly, Regazzoni et al, recently showed in a series malignancy and chemotherapy. of cancer patients admitted to the ICU for septic shock, that both neutropenic and nonneutropenic patients had Conversely, a recent study from Pene et al, reported similar outcomes in terms of mortality and length of stay 209 patients with allogeneic HSCT admitted to three in the ICU, compared to patients with normal neutrophil French ICUs. [42] Among them, 122 patients required count. [37] In these studies and the study by Blot et al, mechanical ventilation. The overall in-ICU, in-Hospital outcomes were related to the severity and the number of and six-month survival rate in mechanically ventilated organ failures. [9, 15, 30, 35, 37] Consequently, neutropenia, even patients were 18%, 15.6% and 14%, respectively. when prolonged, should not be taken into account in the Mechanical ventilation, vasoactive drugs, corticosteroid decision to admit or refuse admission to an intensive care treatments and high bilirubin levels were independently unit. Moreover, the care of neutropenic patients in the associated with mortality, whereas interval time from ICU should not be different from the critically ill cancer HCST and ICU < 30 day was associated with survival. patients with normal leukocyte count.
The conclusion was that ICU admission, mechanical ventilation and maximal organ support may be justifi ed in Hematopoietic stem cell transplantation patients at the early stage of allogeneic HSCT, but should Similarly to neutropenia, allogeneic hematopoietic be discouraged in patients treated with corticosteroids stem cell transplantation (HSCT) has been associated for GVHD. with bad prognosis when patients experienced lifethreatening complications. Several studies reported Chemotherapy in the ICU mortality rates of 85-90% when mechanical ventilation Some patients are presenting with newly diagnosed was required [38] [39] [40] [41] and 100% if the mechanical ventilation malignancies and acute life-threatening complications was associated with hemodynamic instability, renal requiring admission to an ICU. The main disorders are failure or hepatic failure, suggesting that life sustaining infection and organ involvement by cancer, such as treatments should be discontinued in these patients. [7] pulmonary leukemic infiltration, central nervous system However, recent studies have highlighted this issue and involvement, bulky mediastinal tumor, hemophagocytosis have allowed intensivists to a reappraisal. Until recently, all the studies evaluating HSCT pooled patients receiving autologous and allogeneic HSCT. This led to confusion in the results because of major differences between the two procedures: allogeneic HSCT involves immunological conflict between donor's hematopoietic stem cells and host, which results in graft versus host disease (GVHD) and deep immunodeficiency, whereas autologous HSCT only involves intensive chemotherapy and infusion of the own patient's stem cell with no immunological conflict. Since prognosis of life-threatening complications in or tumor lysis syndrome. In these patients, the prompt control of the malignancy is the only way of ensuring recovery and immediate cancer chemotherapy has to be initiated in the ICU in addition to usual life-sustaining interventions. We recently reported 100 patients who underwent cancer chemotherapy in the ICU for newly diagnosed malignancies, in whom survival rate was 60% and 49% at 30-days and six-months respectively. [15] As reported in the majority of the studies, factors independently associated with mortality were related to organ failure: need for vasopressors, mechanical ventilation and liver failure. Among the 54 patients requiring endotracheal mechanical ventilation, 19 survived at day 30 (35%). This study highlighted the feasibility of cancer chemotherapy in the ICU, along with organ failure and life-sustaining therapies.
Appropriateness of the Decision to Refuse Admission
Definite criteria to ensure whether admission to the ICU is appropriate are often lacking at the bedside.
to organ failures present at ICU admission. [30] Mortality rate of patients with one, two or three organ failures was 40%, 60% and 90% respectively and among all the organ failures, respiratory failure requiring mechanical ventilation has the strongest effect of outcome. Other studies in nonneutropenic patients reported similar results but with better outcomes. Mortality rates ranged from 18% to 75% in patients with 1 to 5 organ failures admitted to the ICU with newly diagnosed malignancies. [15] However, although organ dysfunction is the cornerstone Inappropriate admission of patients to the ICU may lead of the evaluation of patient's severity, data available to inadequate utilisation of medical resources and futility. on admission cannot accurately discriminate between On the opposite, inappropriate denial for admission of patients who are likely to survive and others. [20, 30] In this a patient to the ICU may result in the worsening of life-regard, the course of organ dysfunction over the first threatening conditions and increase the risk of death. days of life-sustaining treatment seems to be of critical We evaluated the appropriateness of ICU refusal in a value to predict outcome. In patients with hematological prospective longitudinal study over a one-year study malignancies, the loss of two or more organ failures in our hospital.
[11] All patients for whom admission was at day five was associated with 29% 30-day mortality requested were followed-up during six months, regardless rate, whereas patients in whom the number of organ of whether admission was granted or not. Our results dysfunction did not decrease or increased had a 81% showed that errors in judgement by the intensivist who 30-day mortality rate.
[13] Moreover, time from admission to decided to refuse admission were frequent and may initiation of vasopressors, mechanical ventilation or renal translate into increased mortality for the patients.
[11] Thirty-replacement therapy seems to be highly correlated to day mortality was 21.6%, for patients who were refused prognosis. Thus, in a recent study including 108 critically admission because they were considered too well to ill cancer patients with at least 2 organ failures, we benefit from ICU admission and 74% for patients who found no survivors among patients in whom mechanical were refused admission because they were considered ventilation, vasopressors or renal replacement therapy too ill to benefit from ICU admission. These results was initiated after day three. [43, 44] These results suggest show the inaccurate clinical judgement by intensive care that organ failures occurring in the course of the ICU stay physicians for both patients considered too well or too have more influence on the outcome than organ failures sick to benefit and suggest that tools are lacking to the present at admission. Consequently, the course of organ intensivist at the bed side and at the time of ICU proposal, failures over the first days of full life-sustaining treatment to discriminate which patients are likely to benefi t from could be a simple and objective tool for intensivists to ICU admission. [11] identify patients who are likely to die and those who are likely to survive. Patients in whom the number and We suggest the following admission policy for ICU severity of organ dysfunction are decreasing are likely admission: first, patients with poor performance status to survive and may benefit from the continuation of and with no cancer treatment options should not be aggressive care. By contrast, patients in whom organ considered for ICU admission; second, a broad policy of admission to the ICU can be considered, with the aim to avoid inappropriate ICU refusal.
Serial Evaluation of Organ Dysfunction:
The Key for Prognostic Evaluation
As frequently reported, the main determinants of mortality in critically ill cancer patients are the severity and the number of organ failures. [13, 15, 20, 30] Blot et al, evaluated the prognosis of neutropenic patients according failures does not decrease or patients who experience new organ dysfunction within the first days of intensive care, should be discussed for withdrawal or withdrawing of life sustaining therapies. [43, 44] Because data available at ICU admission are not accurate enough to predict prognosis and since patients with no hope for survival are easy to identify after an "ICU trial", we suggest a strategy based on broad ICU admission, life-sustaining treatment for few days and daily This strategy, which is an alternative to ICU refusal in high severity patients, allows clinicians to better appraise the prognosis and relieves families from guilt due to a perception that nonadmission leads to loss of chance. Of course, patients with cancer for which potentially no lifespan-extending treatment is available or who are bedridden should not be admitted to the ICU and should Therefore, in patients with hematological malignancies, low severity of organ failures could be interpreted as predictor of further deterioration. Early transfer to the ICU should be discussed for these patients.
In this regard, good co-operation between onco hematologists and intensivists is the cornerstone of early identification and management of these patients. A recent survey performed in 10 French hospitals, onco be excluded of this approach.
hematologists and intensivists were asked about the criteria upon which they commonly base their decision Nevertheless, this strategy might be associated with an to refer of to admit cancer patients to the ICU. Sixty-three increased proportion of deaths occurring after treatment-per cent of the intensivists appreciate to admit patients limitation decisions. This may translate into increased early in the course of organ failure, compared to 32% of burden on the nurses and physicians and into a higher the onco-hematologists. [47] rate of conflicts.
[44]
Conclusion Early ICU Management in Low
Over the last decade, outcome in cancer patients
Severity Patients
admitted to the ICU has improved. Classic predictors Bedside evaluation of patients with low severity is also of outcome of critically ill cancer patients are no inaccurate.
[11] In our series, 21% of patients who were longer relevant. We suggest a three-step decision refused admission because of lack of severity died before making process for deciding ICU-admission in cancer day 30, suggesting that ICU admission might have been patients. First, our policy discourages ICU-admission inappropriately denied. Since all of these patients were in uncontrolled malignancies and no therapeutic option finally admitted less than 24h after the initial proposal, available for cancer treatment; in bedridden patients one can hypothesise that the delay before ICU admission or those who underwent allogenic bone marrow might have influenced the patient's prognosis. That transplantation complicated by active GVHD. Second, point has been raised by Sprung et al, in non cancer ICU-admission should be unlimited in patients with newly patients, who reported higher mortality rates in patient diagnosed malignancies. Last, in all other patients, an later admitted, compared to patients rapidly admitted to ICU trial should be considered. It consists in an unlimited the ICU.
[45] Therefore, early identification of patients who level of care for a limited time period after which serial need to be carefully monitored or patients at risk to develop evaluation of organ dysfunctions might provide a more organ failure is an important issue. In a recent study, 53 accurate estimation of survival than at admission. In patients with hematological malignancies who developed low severity patients, future research should identify the pneumonia have been followed-up from the onset of the adequate place for patients with only one organ failure, pneumonia.
[46] Approximately half of them (45%) required but potentially subsequent deterioration. transfer to the ICU. Simple factors, such as the need of more than 3L/min of 02 supplementation to achieve SpO2>92% and more than one quadrant involved at the time of onset of the pneumonia were highly associated with ICU admission. Predictive value of more than 3L/min of supplemental O2 to achieve SpO2>92% at the onset of the pneumonia has a positive predictive value of transfer to the ICU of 95%. The authors did not recommend that hematologists should decide a transfer to the ICU at this value, but that these patients should be carefully monitored. The interesting point of this study is that the cut off value of 3L/min is usually too low to require a transfer to the ICU. ) .
